Tony Opipari

Dr. Opipari is a physician scientist with experience in academic medicine and leading translational and clinical research in the biopharmaceutical industry. Prior to Odyssey, he co-founded Lycera, Firstwave Bio, and IFM Therapeutics; in each company, he led research in translational medicine and directed early clinical development. Prior to the biotech industry, he was a member of the faculty of the University of Michigan Medical School with an appointment in the Division of Gynecological Oncology. Dr. Opipari received his M.D., Ph.D. and completed post-graduate medical training at the University of Michigan.